Oligogenic basis of isolated gonadotropin-releasing hormone deficiency

Between the genetic extremes of rare monogenic and common polygenic diseases lie diverse oligogenic disorders involving mutations in more than one locus in each affected individual. Elucidating the principles of oligogenic inheritance and mechanisms of genetic interactions could help unravel the new...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 107; no. 34; pp. 15140 - 15144
Main Authors Sykiotis, Gerasimos P., Plummer, Lacey, Hughes, Virginia A., Au, Margaret, Durrani, Sadia, Nayak-Young, Sadhana, Dwyer, Andrew A., Quinton, Richard, Hall, Janet E., Gusella, James F., Seminara, Stephanie B., Crowley, William F., Pitteloud, Nelly, Donahoe, Patricia K.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 24.08.2010
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Between the genetic extremes of rare monogenic and common polygenic diseases lie diverse oligogenic disorders involving mutations in more than one locus in each affected individual. Elucidating the principles of oligogenic inheritance and mechanisms of genetic interactions could help unravel the newly appreciated role of rare sequence variants in polygenic disorders. With few exceptions, however, the precise genetic architecture of oligogenic diseases remains unknown. Isolated gonadotropin-releasing hormone (GnRH) deficiency caused by defective secretion or action of hypothalamic GnRH is a rare genetic disease that manifests as sexual immaturity and infertility. Recent reports of patients who harbor pathogenic rare variants in more than one gene have challenged the long-held view that the disorder is strictly monogenic, yet the frequency and extent of oligogenicity in isolated GnRH deficiency have not been investigated. By systematically defining genetic variants in large cohorts of well-phenotyped patients (n = 397), family members, and unaffected subjects (n = 179) for the majority of known disease genes, this study suggests a significant role of oligogenicity in this disease. Remarkably, oligogenicity in isolated GnRH deficiency was as frequent as homozygosity/compound heterozygosity at a single locus (2.5%). Among the 22% of patients with detectable rare protein-altering variants, the likelihood of oligogenicity was 11.3%. No oligogenicity was detected among controls (P < 0.05), even though deleterious variants were present. Viewing isolated GnRH deficiency as an oligogenic condition has implications for understanding the pathogenesis of its reproductive and nonreproductive phenotypes; deciphering the etiology of common GnRH-related disorders; and modeling the genetic architecture of other oligogenic and multifactorial diseases.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
Author contributions: G.P.S. and N.P. designed research; G.P.S., L.P., V.A.H., M.A., S.D., S.N.-Y., A.A.D., R.Q., J.E.H., S.B.S., W.F.C., and N.P. performed research; G.P.S., L.P., V.A.H., J.F.G., and N.P. analyzed data; and G.P.S., W.F.C., and N.P. wrote the paper.
Communicated by Patricia K. Donahoe, Massachusetts General Hospital, Boston, MA, June 30, 2010 (received for review May 2, 2010)
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1009622107